<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:c12f4823-c17a-4035-a1e3-9ec0faba8f5f,g:7ce9e3b9-c0d7-4e9f-a58c-584c47edd614,d:43b65d805eb047c285572366671614ca--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mgnx-20220519</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV80L2ZyYWc6MTQzMzE2YjdjOTU1NGI2NDkxNzJkNzZkNTczYjdlMDMvdGFibGU6OTgzNGY3YjA3ZjRiNGUzZDg0NDAwODY2ZDJjNWI1NzgvdGFibGVyYW5nZTo5ODM0ZjdiMDdmNGI0ZTNkODQ0MDA4NjZkMmM1YjU3OF8yLTEtMS0xLTQ2MTA0_27bdf6f4-5179-469a-b867-e3df4f40e355">0001125345</ix:nonNumeric><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV80L2ZyYWc6MTQzMzE2YjdjOTU1NGI2NDkxNzJkNzZkNTczYjdlMDMvdGFibGU6OTgzNGY3YjA3ZjRiNGUzZDg0NDAwODY2ZDJjNWI1NzgvdGFibGVyYW5nZTo5ODM0ZjdiMDdmNGI0ZTNkODQ0MDA4NjZkMmM1YjU3OF8zLTEtMS0xLTQ2MTA0_7427b1ec-fb4b-4027-a911-164633b22b9c">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mgnx-20220519.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i8b120022d080470980fb44031843ab4f_D20220519-20220519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125345</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-19</xbrli:startDate><xbrli:endDate>2022-05-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i43b65d805eb047c285572366671614ca_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGV4dHJlZ2lvbjo5NWMyOTg1YjE2Njg0OThjYmYyOWE0NzRlYmFlNTkzMl8xNjQ3_9830724c-ca52-460a-ac0e-599d242f5ad6">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Pursuant to Section 13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported):&#160; <ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGV4dHJlZ2lvbjo5NWMyOTg1YjE2Njg0OThjYmYyOWE0NzRlYmFlNTkzMl8yMzI_1d2bae4c-db1b-4f66-9393-d3d82f3e2c13">May 19, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGV4dHJlZ2lvbjo5NWMyOTg1YjE2Njg0OThjYmYyOWE0NzRlYmFlNTkzMl8xNjQ0_db8aa31b-c88c-4b39-abd7-421b10bd1b95">MACROGENICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (Exact Name of Registrant as Specified in Charter)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.948%"><tr><td style="width:1.0%"></td><td style="width:18.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGFibGU6MjYwYWI2MmRhYWJjNDM5MzlhYjEwYTZhZjMwYjM2MTQvdGFibGVyYW5nZToyNjBhYjYyZGFhYmM0MzkzOWFiMTBhNmFmMzBiMzYxNF8wLTAtMS0xLTQ2MTA0_5582c97f-24d3-44b0-b251-32875b706b3e">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGFibGU6MjYwYWI2MmRhYWJjNDM5MzlhYjEwYTZhZjMwYjM2MTQvdGFibGVyYW5nZToyNjBhYjYyZGFhYmM0MzkzOWFiMTBhNmFmMzBiMzYxNF8wLTMtMS0xLTQ2MTA0_29ca6e0d-6de8-4e0f-a56e-78670e12837f">001-36112</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGFibGU6MjYwYWI2MmRhYWJjNDM5MzlhYjEwYTZhZjMwYjM2MTQvdGFibGVyYW5nZToyNjBhYjYyZGFhYmM0MzkzOWFiMTBhNmFmMzBiMzYxNF8wLTUtMS0xLTQ2MTA0_94d5f69d-70b8-4946-b02e-76a0bb60ce13">06-1591613</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(IRS Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;Identification No.)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGFibGU6MjYwYWI2MmRhYWJjNDM5MzlhYjEwYTZhZjMwYjM2MTQvdGFibGVyYW5nZToyNjBhYjYyZGFhYmM0MzkzOWFiMTBhNmFmMzBiMzYxNF8zLTAtMS0xLTQ2MTA0_b6e67d67-f615-4e3b-bedd-4d4ee7ef3d57">9704 Medical Center Drive</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGFibGU6MjYwYWI2MmRhYWJjNDM5MzlhYjEwYTZhZjMwYjM2MTQvdGFibGVyYW5nZToyNjBhYjYyZGFhYmM0MzkzOWFiMTBhNmFmMzBiMzYxNF80LTAtMS0xLTQ2MTA0_b8b2afc3-66f3-4be4-9f10-e86b203e7bed">Rockville,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGFibGU6MjYwYWI2MmRhYWJjNDM5MzlhYjEwYTZhZjMwYjM2MTQvdGFibGVyYW5nZToyNjBhYjYyZGFhYmM0MzkzOWFiMTBhNmFmMzBiMzYxNF80LTEtMS0xLTQ2MTA0_e3212a1c-d328-4931-80b8-b66e72e42c52">Maryland</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGFibGU6MjYwYWI2MmRhYWJjNDM5MzlhYjEwYTZhZjMwYjM2MTQvdGFibGVyYW5nZToyNjBhYjYyZGFhYmM0MzkzOWFiMTBhNmFmMzBiMzYxNF80LTMtMS0xLTQ2MTA0_f6c3ec9e-8c84-4b2d-96fc-dfd7384b3758">20850</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code:&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGV4dHJlZ2lvbjo5NWMyOTg1YjE2Njg0OThjYmYyOWE0NzRlYmFlNTkzMl8xNjQ4_202fd0b4-efdb-4936-96ad-f248b8e44e53">301</ix:nonNumeric>) <ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGV4dHJlZ2lvbjo5NWMyOTg1YjE2Njg0OThjYmYyOWE0NzRlYmFlNTkzMl8xNjQ1_0c820356-f8d2-4572-8b42-3346efc7db45">251-5172</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not applicable&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGFibGU6MzhmMTJmZGZlZTVlNDFiNGJjOTMxOWFjMmM4NDQ4YWMvdGFibGVyYW5nZTozOGYxMmZkZmVlNWU0MWI0YmM5MzE5YWMyYzg0NDhhY18xLTAtMS0xLTQ2MTA0_99186f73-f0f0-469b-9259-14f69e409140">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGFibGU6MzhmMTJmZGZlZTVlNDFiNGJjOTMxOWFjMmM4NDQ4YWMvdGFibGVyYW5nZTozOGYxMmZkZmVlNWU0MWI0YmM5MzE5YWMyYzg0NDhhY18xLTEtMS0xLTQ2MTA0_05a91c15-6012-40d7-a99b-84bd99abef1c">MGNX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGFibGU6MzhmMTJmZGZlZTVlNDFiNGJjOTMxOWFjMmM4NDQ4YWMvdGFibGVyYW5nZTozOGYxMmZkZmVlNWU0MWI0YmM5MzE5YWMyYzg0NDhhY18xLTItMS0xLTQ2MTA0_bf1dd466-2a80-4b0c-bee9-eecf3e37303f">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:5.25pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-bottom:3pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGV4dHJlZ2lvbjo5NWMyOTg1YjE2Njg0OThjYmYyOWE0NzRlYmFlNTkzMl8xNjQ2_df2717e9-0e0a-47aa-b9e5-be492662b87f">&#9744;</ix:nonNumeric> Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:3pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGV4dHJlZ2lvbjo5NWMyOTg1YjE2Njg0OThjYmYyOWE0NzRlYmFlNTkzMl8xNjQw_cb299985-ad24-4927-a35b-3d49e6160b57">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:3pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGV4dHJlZ2lvbjo5NWMyOTg1YjE2Njg0OThjYmYyOWE0NzRlYmFlNTkzMl8xNjQx_526706f9-c643-41fa-acc3-7d17845b8a75">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGV4dHJlZ2lvbjo5NWMyOTg1YjE2Njg0OThjYmYyOWE0NzRlYmFlNTkzMl8xNjQy_11cb3d0c-0a9b-4567-a988-402442be5ce2">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  <ix:nonNumeric contextRef="i8b120022d080470980fb44031843ab4f_D20220519-20220519" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQzYjY1ZDgwNWViMDQ3YzI4NTU3MjM2NjY3MTYxNGNhL3NlYzo0M2I2NWQ4MDVlYjA0N2MyODU1NzIzNjY2NzE2MTRjYV8xL2ZyYWc6OTVjMjk4NWIxNjY4NDk4Y2JmMjlhNDc0ZWJhZTU5MzIvdGV4dHJlZ2lvbjo5NWMyOTg1YjE2Njg0OThjYmYyOWE0NzRlYmFlNTkzMl8xNjQz_ca3a7518-31e3-47e7-ac75-a4dc91b6fd6c">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   &#9744;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i43b65d805eb047c285572366671614ca_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Item 5.07</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Submission of Matters to a Vote of Security Holders.</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MacroGenics, Inc. (the "Company") held its 2022 Annual Meeting of Stockholders on May&#160;19, 2022.  A total of 49,568,059 shares of the Company's common stock were present or represented by proxy at the meeting, which represented approximately 81% of the Company's  61,324,758 shares of common stock that were outstanding and entitled to vote at the meeting as of the record date of March 25, 2022. Stockholders considered the four proposals outlined below, each of which is described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 8, 2022 (the "Proxy Statement").</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:112%">Proposal 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">. The election of two nominees to serve as Class III directors, each for a term of three years. Both director nominees were elected. The voting results were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.634%"><tr><td style="width:1.0%"></td><td style="width:29.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.137%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.137%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.467%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Nominees</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">For</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Withheld</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Karen Ferrante, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">33,151,161</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13,705,407</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,711,490</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Edward Hurwitz</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">31,370,473</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15,486,095</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,711,490</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Proposal 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The ratification of the appointment by the Audit Committee </span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of the Board of Directors of the Company (the "Board") </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for fiscal year 2022. Proposal 2 was approved. The voting results were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.698%"><tr><td style="width:1.0%"></td><td style="width:20.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">For</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Against</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Abstain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">49,483,239</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">72,641</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12,180</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Proposal 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. Stockholders approved the compensation of the Company's named executive officers. The voting results were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.698%"><tr><td style="width:1.0%"></td><td style="width:20.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">For</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Against</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Abstain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">44,883,740</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,964,657</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,171</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,711,490</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Proposal 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To approve, on an advisory basis, the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers. The stockholders approved, on a non-binding advisory basis, to hold future non-binding advisory votes to approve the compensation of the Company's named executive officers every year.  The voting results were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1 year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Abstain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">45,728,324</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,316</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,106,954</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15,975</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2,711,490</span></td></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In light of this result, the Board determined to hold future non-binding, advisory votes on executive compensation every year, so that the next such vote will be held at the Company's 2023 Annual Meeting of Stockholders. Under Section 14A(a)(2) of the Securities Exchange Act of 1934, as amended, the Company will hold the next non-binding, advisory vote on the frequency of holding a non-binding, advisory vote on the Company's executive compensation no later than its 2028 Annual Meeting of Stockholders.</span></div><div id="i43b65d805eb047c285572366671614ca_10"></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MACROGENICS, INC.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date:  May 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:</span></div><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name:</span></div><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ Jeffrey Peters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Jeffrey Peters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vice President and General Counsel</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "mgnx-20220519.htm", "description": "8-K", "secsgml_size_bytes": 47359}]
{"company-data": {"conformed-name": "MACROGENICS INC", "cik": "0001125345", "assigned-sic": "2834", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-36112", "film-number": "22952596"}, "business-address": {"street1": "9704 MEDICAL CENTER DRIVE", "city": "Rockville", "state": "MD", "zip": "20850", "phone": "301-251-5172"}, "mail-address": {"street1": "9704 MEDICAL CENTER DRIVE", "city": "ROCKVILLE", "state": "MD", "zip": "20850"}}
mgnx-20220519
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
May 19, 2022
MACROGENICS, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware
001-36112
06-1591613
(State or Other Jurisdiction of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
9704 Medical Center Drive
Rockville,
Maryland
20850
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code:
(
301
)
251-5172
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
MGNX
Nasdaq Global Select Market
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐
Item 5.07
Submission of Matters to a Vote of Security Holders.
MacroGenics, Inc. (the "Company") held its 2022 Annual Meeting of Stockholders on May 19, 2022.  A total of 49,568,059 shares of the Company's common stock were present or represented by proxy at the meeting, which represented approximately 81% of the Company's  61,324,758 shares of common stock that were outstanding and entitled to vote at the meeting as of the record date of March 25, 2022. Stockholders considered the four proposals outlined below, each of which is described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 8, 2022 (the "Proxy Statement").
Proposal 1
. The election of two nominees to serve as Class III directors, each for a term of three years. Both director nominees were elected. The voting results were as follows:
Nominees
For
Withheld
Broker Non-Votes
Karen Ferrante, M.D.
33,151,161
13,705,407
2,711,490
Edward Hurwitz
31,370,473
15,486,095
2,711,490
Proposal 2
. The ratification of the appointment by the Audit Committee
of the Board of Directors of the Company (the "Board")
of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2022. Proposal 2 was approved. The voting results were as follows:
For
Against
Abstain
Broker Non-Votes
49,483,239
72,641
12,180
—
Proposal 3
. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. Stockholders approved the compensation of the Company's named executive officers. The voting results were as follows:
For
Against
Abstain
Broker Non-Votes
44,883,740
1,964,657
8,171
2,711,490
Proposal 4
. To approve, on an advisory basis, the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers. The stockholders approved, on a non-binding advisory basis, to hold future non-binding advisory votes to approve the compensation of the Company's named executive officers every year.  The voting results were as follows:
1 year
2 years
3 years
Abstain
Broker Non-Votes
45,728,324
5,316
1,106,954
15,975
2,711,490
In light of this result, the Board determined to hold future non-binding, advisory votes on executive compensation every year, so that the next such vote will be held at the Company's 2023 Annual Meeting of Stockholders. Under Section 14A(a)(2) of the Securities Exchange Act of 1934, as amended, the Company will hold the next non-binding, advisory vote on the frequency of holding a non-binding, advisory vote on the Company's executive compensation no later than its 2028 Annual Meeting of Stockholders.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MACROGENICS, INC.
Date:  May 23, 2022
By:
Name:
Title:
/s/ Jeffrey Peters
Jeffrey Peters
Vice President and General Counsel